Update on Functional Heartburn
Abstract
The definition of functional heartburn has been refined over the years. It is currently described, based upon Rome IV criteria, as typical heartburn symptoms in the presence of normal upper endoscopy findings (including normal biopsies), normal esophageal pH testing, and a negative association between symptoms and reflux events. Functional heartburn is very common, affecting women more than men, and with reflux hypersensitivity makes up the majority of heartburn patients who fail twice-daily proton pump inhibitor therapy. These disorders overlap with other functional gastrointestinal disorders and are often accompanied by psychological comorbidities. Diagnosis is made by using endoscopy with esophageal biopsies, wireless pH capsule, pH-impedance monitoring, and high-resolution esophageal manometry. Additional diagnostic tools that may be of value include magnification endoscopy, chromoendoscopy, narrow-band imaging, autofluorescence imaging, mucosal impedance, impedance baseline values, and histopathology scores. Functional heartburn is primarily treated with neuromodulators. Psychological intervention and complementary and alternative medicine may also play important roles in the treatment of these patients.
Keywords: Heartburn; esophagus; pH testing; proton pump inhibitor; upper endoscopy.
Conflict of interest statement
The authors have no relevant conflicts of interest to disclose.
Figures



Similar articles
-
Reflux Hypersensitivity: A New Functional Esophageal Disorder.J Neurogastroenterol Motil. 2017 Oct 30;23(4):495-503. doi: 10.5056/jnm17097. J Neurogastroenterol Motil. 2017. PMID: 28992673 Free PMC article. Review.
-
AGA Clinical Practice Update on Functional Heartburn: Expert Review.Gastroenterology. 2020 Jun;158(8):2286-2293. doi: 10.1053/j.gastro.2020.01.034. Epub 2020 Feb 1. Gastroenterology. 2020. PMID: 32017911 Review.
-
Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients.World J Gastroenterol. 2015 Apr 28;21(16):5009-16. doi: 10.3748/wjg.v21.i16.5009. World J Gastroenterol. 2015. PMID: 25945016 Free PMC article.
-
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.Dig Liver Dis. 2011 Jul;43(7):542-7. doi: 10.1016/j.dld.2011.01.016. Epub 2011 Mar 3. Dig Liver Dis. 2011. PMID: 21376679
-
Untangling Nonerosive Reflux Disease From Functional Heartburn.Clin Gastroenterol Hepatol. 2021 Jul;19(7):1314-1326. doi: 10.1016/j.cgh.2020.03.057. Epub 2020 Apr 1. Clin Gastroenterol Hepatol. 2021. PMID: 32246998 Review.
Cited by
-
Extra-Esophageal Presentation of Gastroesophageal Reflux Disease: 2020 Update.J Clin Med. 2020 Aug 7;9(8):2559. doi: 10.3390/jcm9082559. J Clin Med. 2020. PMID: 32784573 Free PMC article. Review.
-
Psychological Characteristics and Quality of Life of Patients with Upper and Lower Functional Gastrointestinal Disorders.J Clin Med. 2022 Dec 23;12(1):124. doi: 10.3390/jcm12010124. J Clin Med. 2022. PMID: 36614925 Free PMC article.
-
Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease.Ann Med. 2024 Dec;56(1):2354683. doi: 10.1080/07853890.2024.2354683. Epub 2024 May 16. Ann Med. 2024. PMID: 38753973 Free PMC article. Clinical Trial.
-
Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders.Front Pharmacol. 2023 May 22;14:1131354. doi: 10.3389/fphar.2023.1131354. eCollection 2023. Front Pharmacol. 2023. PMID: 37284319 Free PMC article.
-
The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness.Curr Gastroenterol Rep. 2018 Jun 9;20(7):34. doi: 10.1007/s11894-018-0641-x. Curr Gastroenterol Rep. 2018. PMID: 29886565 Review.
References
-
- Drossman DA, Corazziari R, Talley NJ, et al. Rome II: The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Consensus. 2nd ed. McLean, VA: Degnon Associates; 2000.
-
- Drossman DA. Rome III: The Functional Gastrointestinal Disorders. 3rd ed. McLean, VA: Degnon Associates; 2006.
-
- Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease—where next? Aliment Pharmacol Ther. 2005;22(2):79–94. - PubMed
-
- Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology. 1998;115(6):1363–1373. - PubMed
-
- Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150(6):1262–1279.e2. - PubMed
LinkOut - more resources
Full Text Sources